13D Filing: Coliseum Capital and Bioscrip Inc. (BIOS)

Page 5 of 10

Page 5 of 10 – SEC Filing


CUSIP No. 09069N108 (Common Stock)

  1.

Names of
Reporting Persons.

Coliseum Capital Partners II, L.P.

  2.

Check the Appropriate Box if a Member
of a Group (See Instructions)

(a)  ☐        (b)  ☒

  3.

SEC Use Only

  4.

Source of Funds (See Instructions)

WC

  5.

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)

  6.

Citizenship or Place of
Organization

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  7.

Sole Voting Power

0

  8.

Shared Voting Power

3,425,232 (1)

  9.

Sole Dispositive Power

0

10.

Shared Dispositive Power

3,425,232 (1)

11.

Aggregate Amount Beneficially Owned by Each Reporting Person

3,425,232 (1)

12.

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares (See Instructions)

13.

Percent of Class Represented by
Amount in Row (11)

2.6% (1)

14.

Type of Reporting Person (See
Instructions)

PN

(1) Includes (a) 682,160 Common Shares, (b) 38,728 Common Shares that could be obtained upon conversion of 1,525 Series A Preferred Shares, (c) 2,197,206 Common Shares that could be obtained upon conversion of 86,520 Series
C Preferred Shares, (d) 253,569 Common Shares that could be obtained upon conversion of 253,569 Class A Warrants, and (e) 253,569 Common Shares that could be obtained upon conversion of 253,569 Class B Warrants.

Page 5 of 10

Follow Option Care Health Inc. (NASDAQ:OPCH)

Page 5 of 10